Estudio realizado en la población de Taiwan

Riesgo de cáncer en los pacientes con infección por herpes zóster

Este estudio basado en registros nacionales no comprobó que el herpes zóster se asocie a un mayor riesgo de cáncer subsecuente en la población general.

Autor/a: Dres. Yu-Ping Wang, Chia-Jen Liu, Yu-Wen Hu, Tzeng-Ji Chen, Yi-Tsung Lin, Chang-Phone Fung

Fuente: CMAJ 2012. DOI:10.1503

Indice
1. Referencias
2. Artículo

Referencias

1. Jih JS, Chen YJ, Lin MW, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol 2009;89:612-6.
2. McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009;48:1364-71.
3. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
4. Wung PK, Holbrook JT, Hoffman GS, et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med 2005;118:1416.
5. Smith JB, Fenske NA. Herpes zoster and internal malignancy. South Med J 1995;88:1089-92.
6. Goffinet DR, Glatstein EJ, Merigan TC. Herpes Zoster-Varicella infections and lymphoma. Ann Intern Med 1972;76:235-40.
7. Schimpff S, Serpick A, Stoler B, et al. Varicella-Zoster infection in patients with cancer. Ann Intern Med 1972;76:241-54.
8. Wyburn-Mason R. Malignant change arising in tissues affected by herpes. BMJ 1955;2:1106-9.
9. Ragozzino MW, Melton LJ III, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982; 307:393-7.
10. Buntinx F, Wachana R, Bartholomeeusen S, et al. Is herpes zoster a marker for occult or subsequent malignancy? Br J Gen Pract 2005;55:102-7.
11. Sørensen HT, Olsen JH, Jepsen P, et al. The risk and prognosis of cancer after hospitalisation for herpes zoster: a populationbased follow-up study. Br J Cancer 2004;91:1275-9.
12. Yamamoto M, Mine H, Akazawa K, et al. Gastrointestinal cancer and herpes zoster in adults. Hepatogastroenterology 2003;50: 1043-6.
13. Ho JD, Xirasagar S, Lin HC. Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide populationbased study. Ophthalmology 2011;118:1076-81.
14. Tsan YT, Lee CH, Wang JD, et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012; 30:623-30.
15. Yang YW, Chen YH, Wang KH, et al. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ 2011;183:E275-80.
16. Lin YT, Liu CJ, Chen TJ, et al. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med 2011;124:1158-64.
17. Chen YJ, Chang YT, Wang CB, et al. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 2010; 123:1150.e1-6.
18. Kang JH, Sheu JJ, Lin HC. Increased risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis 2010;51:525-30.
19. Kuo CC, Lee CT, Lee IM, et al. Risk of herpes zoster in patients treated with long-term hemodialysis:   matched cohort study. Am J Kidney Dis 2012;59:428-33.
20. Müssig K, Staiger H, Kantartzis K, et al. Type 2 diabetes mellitus and risk of malignancy: Is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism? Diabet Med 2011;28: 276-86.
21. Landgren AM, Landgren O, Gridley G, et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117:1163-71.
22. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: A meta-analysis. Arch Intern Med 2005;165:2337-44.